DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score

Roach, 2000, Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials, Int J Radiat Oncol Biol Phys, 47, 609, 10.1016/S0360-3016(00)00578-2 Heidenreich, 2002, Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis, J Urol, 167, 1681, 10.1016/S0022-5347(05)65177-4 Radwan, 2017, A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE), BMC Cancer, 17, 453, 10.1186/s12885-017-3455-6 Ost, 2018, Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial, J Clin Oncol, 36, 446, 10.1200/JCO.2017.75.4853 Roach, 2006, Whole-pelvis, “mini-pelvis,” or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial, Int J Radiat Oncol Biol Phys, 66, 647, 10.1016/j.ijrobp.2006.05.074 Roach, 2003, Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413, J Clin Oncol, 21, 1904, 10.1200/JCO.2003.05.004 Lawton, 2007, An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94–13, with emphasis on unexpected hormone/radiation interactions, Int J Radiat Oncol Biol Phys, 69, 646, 10.1016/j.ijrobp.2007.04.003 Morikawa, 2011, Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions, Int J Radiat Oncol Biol Phys, 80, 6, 10.1016/j.ijrobp.2010.11.074 Bolla, 2009, Duration of androgen suppression in the treatment of prostate cancer, N Engl J Med, 360, 2516, 10.1056/NEJMoa0810095 Murthy, 2021, Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial, J Clin Oncol, 39, 1234, 10.1200/JCO.20.03282 Roach, 2018, Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial, Lancet Oncol, 19, 1504, 10.1016/S1470-2045(18)30528-X Pommier, 2007, Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01, J Clin Oncol, 25, 5366, 10.1200/JCO.2006.10.5171 Pommier, 2016, Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study, Int J Radiat Oncol Biol Phys, 96, 759, 10.1016/j.ijrobp.2016.06.2455 Pollack, 2022, The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial, Lancet (London, England), 399, 1886, 10.1016/S0140-6736(21)01790-6 Roach, 1994, Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer, Int J Radiat Oncol Biol Phys, 28, 33, 10.1016/0360-3016(94)90138-4 Wu, 2020, Genome-wide plasma DNA methylation features of metastatic prostate cancer, J Clin invest, 130, 1991, 10.1172/JCI130887 Chen, 2022, The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors, Nat Commun, 13, 6467, 10.1038/s41467-022-34012-2 Liu, 2022, Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers, Genomics, 114, 10.1016/j.ygeno.2022.110474 Xu, 2019, Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data, J Transl Med, 17, 311, 10.1186/s12967-019-2065-2 General Assembly of the World Medical, A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent 81, 14-18 (2014). Massie, 2017, The importance of DNA methylation in prostate cancer development, J Steroid Biochem Mol Biol, 166, 1, 10.1016/j.jsbmb.2016.04.009 Zhao, 2020, The DNA methylation landscape of advanced prostate cancer, Nat Genet, 52, 778, 10.1038/s41588-020-0648-8 Delgado-Cruzata, 2012, DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer, DNA Cell Biol, 31, 187, 10.1089/dna.2011.1311 Wang, 2020, Epigenetic regulation of prostate cancer, Genes Dis, 7, 606, 10.1016/j.gendis.2019.10.018 Ngollo, 2017, Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression, BMC Cancer, 17, 261, 10.1186/s12885-017-3256-y Lin, 2019, H3K27 trimethylation and H3K9 dimethylation as poor prognostic markers for patients with esophageal squamous cell carcinoma, Int J Clin Exp Path, 12, 2657 Ellinger, 2014, Alterations of global histone H3K9 and H3K27 methylation levels in bladder cancer, Urol Int, 93, 113, 10.1159/000355467 Cui, 2018, DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer, Oncogene, 37, 4358, 10.1038/s41388-018-0285-1 Sasidharan Nair, 2018, DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer, Clin Epigenetics, 10, 78, 10.1186/s13148-018-0512-1 Di Ruscio, 2022, Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle, Diagnostics (Basel), 12 Wang, 2022, The evolving role of immune cells in prostate cancer, Cancer Lett, 525, 9, 10.1016/j.canlet.2021.10.027 Wu, 2020, The Landscape of Immune Cells Infiltrating in Prostate Cancer, Front Oncol, 10, 10.3389/fonc.2020.517637 Wang, 2018, Regulation of prostate cancer by hormone-responsive G protein-coupled receptors, Pharmacol Ther, 191, 135, 10.1016/j.pharmthera.2018.06.005 Gao, 2021, Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition, Cell Death Differ, 28, 2818, 10.1038/s41418-021-00786-z Graham, 2017, Telomeres and telomerase in prostate cancer development and therapy, Nat Rev Urol, 14, 607, 10.1038/nrurol.2017.104 Olson, 2019, The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression, PLoS Genet, 15, e1008451, 10.1371/journal.pgen.1008451 Ilic, 2017, Ubiquitin C-terminal hydrolase isozyme L1 is associated with shelterin complex at interstitial telomeric sites, Epigenetics Chromatin, 10, 54, 10.1186/s13072-017-0160-2